Presenter: Chris Dalton, Syncopation Software
Presented at the 2017 DAAG Conference in New Orleans, Louisiana. In Session 5: Learning and Organization
Abstract:This talk will discuss probability assessment in the context of pharma/biotech R&D portfolio management, including the role of historical data and project-specific adjustments. An approach to tailoring probabilities while respecting aggregate benchmarks will be proposed and tried out in a group exercise.
Keywords: probability assessment probass, risk and uncertainty riskunc, benchmarks